Elanco Animal Health (ELAN) Competitors $14.50 +1.64 (+12.75%) (As of 11/7/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ELAN vs. TEVA, MRNA, BGNE, GMAB, VTRS, SMMT, RDY, PCVX, SRPT, and CTLTShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), Moderna (MRNA), BeiGene (BGNE), Genmab A/S (GMAB), Viatris (VTRS), Summit Therapeutics (SMMT), Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), Sarepta Therapeutics (SRPT), and Catalent (CTLT). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Teva Pharmaceutical Industries Moderna BeiGene Genmab A/S Viatris Summit Therapeutics Dr. Reddy's Laboratories Vaxcyte Sarepta Therapeutics Catalent Teva Pharmaceutical Industries (NYSE:TEVA) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, community ranking, risk, analyst recommendations, earnings, dividends and profitability. Is TEVA or ELAN more profitable? Teva Pharmaceutical Industries has a net margin of -2.73% compared to Elanco Animal Health's net margin of -27.94%. Teva Pharmaceutical Industries' return on equity of 39.66% beat Elanco Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-2.73% 39.66% 6.95% Elanco Animal Health -27.94%7.29%3.14% Do analysts recommend TEVA or ELAN? Teva Pharmaceutical Industries presently has a consensus price target of $19.67, indicating a potential upside of 12.38%. Elanco Animal Health has a consensus price target of $17.00, indicating a potential upside of 17.24%. Given Elanco Animal Health's higher probable upside, analysts clearly believe Elanco Animal Health is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78Elanco Animal Health 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has stronger valuation & earnings, TEVA or ELAN? Teva Pharmaceutical Industries has higher revenue and earnings than Elanco Animal Health. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$15.85B1.25-$559M-$0.39-44.87Elanco Animal Health$4.42B1.62-$1.23B-$2.55-5.69 Does the media refer more to TEVA or ELAN? In the previous week, Elanco Animal Health had 12 more articles in the media than Teva Pharmaceutical Industries. MarketBeat recorded 41 mentions for Elanco Animal Health and 29 mentions for Teva Pharmaceutical Industries. Teva Pharmaceutical Industries' average media sentiment score of 0.34 beat Elanco Animal Health's score of 0.09 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 9 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 4 Very Positive mention(s) 3 Positive mention(s) 29 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in TEVA or ELAN? 54.1% of Teva Pharmaceutical Industries shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are owned by company insiders. Comparatively, 0.6% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in TEVA or ELAN? Teva Pharmaceutical Industries received 1190 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.77% of users gave Teva Pharmaceutical Industries an outperform vote while only 54.44% of users gave Elanco Animal Health an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes132567.77% Underperform Votes63032.23% Elanco Animal HealthOutperform Votes13554.44% Underperform Votes11345.56% Which has more risk and volatility, TEVA or ELAN? Teva Pharmaceutical Industries has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. SummaryTeva Pharmaceutical Industries beats Elanco Animal Health on 11 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$7.17B$6.85B$5.28B$20.01BDividend YieldN/A7.96%5.10%3.56%P/E Ratio-5.699.00120.0341.75Price / Sales1.62425.851,384.4417.49Price / Cash5.4646.2038.8617.30Price / Book1.155.494.895.25Net Income-$1.23B$154.37M$118.53M$988.95M7 Day Performance14.62%2.66%4.45%4.35%1 Month Performance-0.31%18.43%10.23%3.49%1 Year Performance35.64%40.87%37.53%29.54% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health3.5036 of 5 stars$14.50+12.8%$17.00+17.2%+35.6%$7.17B$4.42B-5.699,300TEVATeva Pharmaceutical Industries2.425 of 5 stars$18.46+0.1%N/A+93.4%$20.91B$15.85B-47.3237,851Earnings ReportAnalyst RevisionMRNAModerna4.5872 of 5 stars$54.63+0.5%N/A-31.7%$20.90B$4.99B-3.555,600Gap UpBGNEBeiGene2.0093 of 5 stars$204.21+0.8%N/A+4.6%$19.88B$3.10B-40.2010,600Upcoming EarningsGMABGenmab A/S4.6415 of 5 stars$22.56+1.1%N/A-21.7%$14.93B$2.39B18.642,204Earnings ReportNews CoveragePositive NewsVTRSViatris2.2824 of 5 stars$11.62+0.2%N/A+44.4%$13.87B$15.43B-21.1338,000Dividend AnnouncementNews CoverageSMMTSummit Therapeutics2.9554 of 5 stars$18.99+2.2%N/A+1,004.7%$13.76B$700,000.00-67.82105Gap UpRDYDr. Reddy's Laboratories1.9221 of 5 stars$74.27+0.5%N/A+16.2%$12.40B$3.35B18.5727,048Analyst UpgradePCVXVaxcyte3.0783 of 5 stars$107.29+0.9%N/A+104.4%$11.97BN/A-22.93160Earnings ReportAnalyst ForecastSRPTSarepta Therapeutics4.9764 of 5 stars$123.29-2.2%N/A+45.2%$11.76B$1.24B273.981,314Analyst ForecastNews CoveragePositive NewsGap UpCTLTCatalent3.1192 of 5 stars$58.73+0.2%N/A+72.0%$10.66B$4.38B-10.7016,900Earnings ReportAnalyst Downgrade Related Companies and Tools Related Companies TEVA Competitors MRNA Competitors BGNE Competitors GMAB Competitors VTRS Competitors SMMT Competitors RDY Competitors PCVX Competitors SRPT Competitors CTLT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ELAN) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELAN Stock Alerts